-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the website of the State Food and Drug Administration, on August 30, the State Food and Drug Administration organized a promotion meeting for the quality supervision of the selected drugs in centralized procurement, summarizing the preliminary work, exchanging supervision experience, analyzing the safety situation, and conducting quality supervision work on the selected drugs in centralized procurement.
Re-emphasize, re-mobilize, re-deploy
.
Huang Guo, member of the party group and deputy director of the State Food and Drug Administration, attended the meeting and delivered a speech
.
Re-emphasize, re-mobilize, re-deploy
.
Huang Guo, member of the party group and deputy director of the State Food and Drug Administration, attended the meeting and delivered a speech
.
The meeting pointed out that promoting the implementation of centralized drug procurement is a major decision of the party and the government to effectively protect the health
and life safety of the people .
Under the background of the normalized and institutionalized development of centralized drug procurement with volume , drug regulatory departments at all levels should further improve their political positions, fully understand the importance of strengthening the supervision of selected drugs in centralized procurement, identify hidden risks and weak links, and strengthen risks.
Prevention and control and hidden danger investigation, keep the bottom line of quality and safety, and serve the overall situation of centralized procurement and medical reform
.
and life safety of the people .
Under the background of the normalized and institutionalized development of centralized drug procurement with volume , drug regulatory departments at all levels should further improve their political positions, fully understand the importance of strengthening the supervision of selected drugs in centralized procurement, identify hidden risks and weak links, and strengthen risks.
Prevention and control and hidden danger investigation, keep the bottom line of quality and safety, and serve the overall situation of centralized procurement and medical reform
.
Huang Guo analyzed the current quality and safety situation of the selected drugs in centralized procurement, and made arrangements for the next step
.
First, focus on compacting the main responsibility of enterprises
.
Strengthen the legal awareness, quality awareness, and compliance awareness of key positions in the enterprise through policy publicity and regulatory training; through full-coverage supervision and inspection and product sampling, urge the enterprise to continue compliant production and operation, and strictly control drug quality risks; urge the enterprise to improve Full life cycle management and implementation of full process traceability management responsibilities
.
The second is to establish and improve the supervision ledger
.
Implement "one enterprise, one policy, one product, one grade" for the selected drugs, adhere to the problem orientation, realize the sharing of regulatory information, and improve the pertinence and effectiveness of supervision by means of information technology
.
The third is to strive to form a synergy of supervision
.
Coordinate the use of various supervisory means, fully dispatch supervisory resources at all levels, improve the inter-departmental collaboration mechanism, identify and control risks in a timely manner, and form a work pattern of joint management
.
.
First, focus on compacting the main responsibility of enterprises
.
Strengthen the legal awareness, quality awareness, and compliance awareness of key positions in the enterprise through policy publicity and regulatory training; through full-coverage supervision and inspection and product sampling, urge the enterprise to continue compliant production and operation, and strictly control drug quality risks; urge the enterprise to improve Full life cycle management and implementation of full process traceability management responsibilities
.
The second is to establish and improve the supervision ledger
.
Implement "one enterprise, one policy, one product, one grade" for the selected drugs, adhere to the problem orientation, realize the sharing of regulatory information, and improve the pertinence and effectiveness of supervision by means of information technology
.
The third is to strive to form a synergy of supervision
.
Coordinate the use of various supervisory means, fully dispatch supervisory resources at all levels, improve the inter-departmental collaboration mechanism, identify and control risks in a timely manner, and form a work pattern of joint management
.
Huang Guo emphasized that the drug regulatory authorities should be brave in their responsibilities, fulfill their responsibilities, pay attention to details, strengthen risk investigation and disposal, and make greater contributions to the overall stability of the country with the stability of drugs in the centralized procurement process.
The Twenty Victories were held
.
The Twenty Victories were held
.
The meeting is held by video
.
At the meeting, the responsible comrades of the drug regulatory authorities in Jiangsu, Zhejiang, Shandong, Guangdong, Sichuan and other places made exchange speeches
.
The person in charge of the Drug Supervision Department of the State Food and Drug Administration, the person in charge of the verification center and the responsible comrades of the relevant offices attended the meeting at the main venue.
The persons in charge of the Drug Administration Bureau of the provinces (autonomous regions and municipalities) and Xinjiang Production and Construction Corps, the Office of Drug Production Supervision and Drug Inspection The person in charge of the organization attended the meeting at the branch venue
.
.
At the meeting, the responsible comrades of the drug regulatory authorities in Jiangsu, Zhejiang, Shandong, Guangdong, Sichuan and other places made exchange speeches
.
The person in charge of the Drug Supervision Department of the State Food and Drug Administration, the person in charge of the verification center and the responsible comrades of the relevant offices attended the meeting at the main venue.
The persons in charge of the Drug Administration Bureau of the provinces (autonomous regions and municipalities) and Xinjiang Production and Construction Corps, the Office of Drug Production Supervision and Drug Inspection The person in charge of the organization attended the meeting at the branch venue
.
According to the website of the State Food and Drug Administration, on August 30, the State Food and Drug Administration organized a promotion meeting for the quality supervision of the selected drugs in centralized procurement, summarizing the preliminary work, exchanging supervision experience, analyzing the safety situation, and conducting quality supervision work on the selected drugs in centralized procurement.
Re-emphasize, re-mobilize, re-deploy
.
Huang Guo, member of the party group and deputy director of the State Food and Drug Administration, attended the meeting and delivered a speech
.
Re-emphasize, re-mobilize, re-deploy
.
Huang Guo, member of the party group and deputy director of the State Food and Drug Administration, attended the meeting and delivered a speech
.
The meeting pointed out that promoting the implementation of centralized drug procurement is a major decision of the party and the government to effectively protect the health
and life safety of the people .
Under the background of the normalized and institutionalized development of centralized drug procurement with volume , drug regulatory departments at all levels should further improve their political positions, fully understand the importance of strengthening the supervision of selected drugs in centralized procurement, identify hidden risks and weak links, and strengthen risks.
Prevention and control and hidden danger investigation, keep the bottom line of quality and safety, and serve the overall situation of centralized procurement and medical reform
.
Health and Wellness Purchasingand life safety of the people .
Under the background of the normalized and institutionalized development of centralized drug procurement with volume , drug regulatory departments at all levels should further improve their political positions, fully understand the importance of strengthening the supervision of selected drugs in centralized procurement, identify hidden risks and weak links, and strengthen risks.
Prevention and control and hidden danger investigation, keep the bottom line of quality and safety, and serve the overall situation of centralized procurement and medical reform
.
Huang Guo analyzed the current quality and safety situation of the selected drugs in centralized procurement, and made arrangements for the next step
.
First, focus on compacting the main responsibility of enterprises
.
Strengthen the legal awareness, quality awareness, and compliance awareness of key positions in the enterprise through policy publicity and regulatory training; through full-coverage supervision and inspection and product sampling, urge the enterprise to continue compliant production and operation, and strictly control drug quality risks; urge the enterprise to improve Full life cycle management and implementation of full process traceability management responsibilities
.
The second is to establish and improve the supervision ledger
.
Implement "one enterprise, one policy, one product, one grade" for the selected drugs, adhere to the problem orientation, realize the sharing of regulatory information, and improve the pertinence and effectiveness of supervision by means of information technology
.
The third is to strive to form a synergy of supervision
.
Coordinate the use of various supervisory means, fully dispatch supervisory resources at all levels, improve the inter-departmental collaboration mechanism, identify and control risks in a timely manner, and form a work pattern of joint management
.
Enterprise Enterprise Regulations and Regulations.
First, focus on compacting the main responsibility of enterprises
.
Strengthen the legal awareness, quality awareness, and compliance awareness of key positions in the enterprise through policy publicity and regulatory training; through full-coverage supervision and inspection and product sampling, urge the enterprise to continue compliant production and operation, and strictly control drug quality risks; urge the enterprise to improve Full life cycle management and implementation of full process traceability management responsibilities
.
The second is to establish and improve the supervision ledger
.
Implement "one enterprise, one policy, one product, one grade" for the selected drugs, adhere to the problem orientation, realize the sharing of regulatory information, and improve the pertinence and effectiveness of supervision by means of information technology
.
The third is to strive to form a synergy of supervision
.
Coordinate the use of various supervisory means, fully dispatch supervisory resources at all levels, improve the inter-departmental collaboration mechanism, identify and control risks in a timely manner, and form a work pattern of joint management
.
Huang Guo emphasized that the drug regulatory authorities should be brave in their responsibilities, fulfill their responsibilities, pay attention to details, strengthen risk investigation and disposal, and make greater contributions to the overall stability of the country with the stability of drugs in the centralized procurement process.
The Twenty Victories were held
.
medicines _The Twenty Victories were held
.
The meeting is held by video
.
At the meeting, the responsible comrades of the drug regulatory authorities in Jiangsu, Zhejiang, Shandong, Guangdong, Sichuan and other places made exchange speeches
.
The person in charge of the Drug Supervision Department of the State Food and Drug Administration, the person in charge of the verification center and the responsible comrades of the relevant offices attended the meeting at the main venue.
The persons in charge of the Drug Administration Bureau of the provinces (autonomous regions and municipalities) and Xinjiang Production and Construction Corps, the Office of Drug Production Supervision and Drug Inspection The person in charge of the organization attended the meeting at the branch venue
.
.
At the meeting, the responsible comrades of the drug regulatory authorities in Jiangsu, Zhejiang, Shandong, Guangdong, Sichuan and other places made exchange speeches
.
The person in charge of the Drug Supervision Department of the State Food and Drug Administration, the person in charge of the verification center and the responsible comrades of the relevant offices attended the meeting at the main venue.
The persons in charge of the Drug Administration Bureau of the provinces (autonomous regions and municipalities) and Xinjiang Production and Construction Corps, the Office of Drug Production Supervision and Drug Inspection The person in charge of the organization attended the meeting at the branch venue
.
